ES2111757T3 - Regiones antigenicas de complejos de particulas liberadas por tumores (tlp) y anticuerpos contra los mismos. - Google Patents

Regiones antigenicas de complejos de particulas liberadas por tumores (tlp) y anticuerpos contra los mismos.

Info

Publication number
ES2111757T3
ES2111757T3 ES93916141T ES93916141T ES2111757T3 ES 2111757 T3 ES2111757 T3 ES 2111757T3 ES 93916141 T ES93916141 T ES 93916141T ES 93916141 T ES93916141 T ES 93916141T ES 2111757 T3 ES2111757 T3 ES 2111757T3
Authority
ES
Spain
Prior art keywords
tlp
tumors
complexes
same
antibodies against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93916141T
Other languages
English (en)
Inventor
Giulio Tarro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Farmacoterapico Italiano SpA
Original Assignee
Istituto Farmacoterapico Italiano SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Farmacoterapico Italiano SpA filed Critical Istituto Farmacoterapico Italiano SpA
Application granted granted Critical
Publication of ES2111757T3 publication Critical patent/ES2111757T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

PEPTIDOS COMPRENDIDOS DENTRO DE PROTEINA 100 KDA DEL COMPLEJO TLP (PROTEINAS LIBERADAS DE TUMORES), TENIENDO ACTIVIDAD ANTIGENICA, ASI COMO ANTICUERPOS PARA ELLOS, CAPACES DE REACCIONAR CON TLP PARA FINES DE DIAGNOSTICOS Y CLINICOS.
ES93916141T 1992-07-03 1993-07-01 Regiones antigenicas de complejos de particulas liberadas por tumores (tlp) y anticuerpos contra los mismos. Expired - Lifetime ES2111757T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920506A IT1262954B (it) 1992-07-03 1992-07-03 Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.

Publications (1)

Publication Number Publication Date
ES2111757T3 true ES2111757T3 (es) 1998-03-16

Family

ID=11401092

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93916141T Expired - Lifetime ES2111757T3 (es) 1992-07-03 1993-07-01 Regiones antigenicas de complejos de particulas liberadas por tumores (tlp) y anticuerpos contra los mismos.

Country Status (14)

Country Link
US (3) US5747643A (es)
EP (1) EP0649433B1 (es)
JP (1) JP2958118B2 (es)
KR (1) KR100237250B1 (es)
AT (1) ATE160359T1 (es)
AU (1) AU680198B2 (es)
BR (1) BR9306663A (es)
CA (1) CA2139518C (es)
DE (1) DE69315341T2 (es)
DK (1) DK0649433T3 (es)
ES (1) ES2111757T3 (es)
IT (1) IT1262954B (es)
RU (1) RU2141969C1 (es)
WO (1) WO1994001458A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1284870B1 (it) 1996-07-10 1998-05-22 Ist Farmacoterapico It Spa Peptidi dei complessi tlp da carcinomi dell'apparato urogenitale e anticorpi diretti contro di essi
IT1294967B1 (it) * 1996-10-09 1999-04-23 Ist Farmacoterapico It Spa Composizione immunogenica da tlp
US20030157116A1 (en) * 2000-02-25 2003-08-21 Giulio Tarro Tlp peptides and dna sequences coding the same
IT1317853B1 (it) * 2000-02-25 2003-07-15 Unihart Corp Peptidi tlp e sequenze di dna che li codificano.
US7056950B2 (en) 2001-02-14 2006-06-06 Matthias Rath Compositions of biochemical compounds involved in bioenergy metabolism of cells
CA2593086A1 (en) 2004-12-30 2006-07-06 Vito Michele Fazio Anti-tumoral immunogenic peptides and vaccine thereof
CA2733672C (en) 2007-08-16 2018-09-11 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
US20100255514A1 (en) 2007-08-16 2010-10-07 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
EP3167898A1 (en) 2015-11-11 2017-05-17 IEO - Istituto Europeo di Oncologia Srl Method for obtaining tumor peptides and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1206250B (it) * 1987-02-18 1989-04-14 Ist Farmacoterapico It Spa Stiche umane e relativi prodotti metodo per l'estrazione di antigeni di membrana aventi proprieta' immunogene a partire da cellule neopla-

Also Published As

Publication number Publication date
DE69315341T2 (de) 1999-03-18
BR9306663A (pt) 1998-12-08
RU94046337A (ru) 1996-10-27
JP2958118B2 (ja) 1999-10-06
RU2141969C1 (ru) 1999-11-27
CA2139518A1 (en) 1994-01-20
AU680198B2 (en) 1997-07-24
ATE160359T1 (de) 1997-12-15
US5747643A (en) 1998-05-05
ITRM920506A0 (it) 1992-07-03
CA2139518C (en) 2003-09-23
EP0649433A1 (en) 1995-04-26
JPH07508749A (ja) 1995-09-28
US5877294A (en) 1999-03-02
DE69315341D1 (de) 1998-01-02
EP0649433B1 (en) 1997-11-19
IT1262954B (it) 1996-07-23
US5759792A (en) 1998-06-02
ITRM920506A1 (it) 1994-01-03
WO1994001458A1 (en) 1994-01-20
DK0649433T3 (da) 1998-07-27
AU4582393A (en) 1994-01-31
KR100237250B1 (ko) 2000-01-15
KR950702207A (ko) 1995-06-19

Similar Documents

Publication Publication Date Title
EA200001023A1 (ru) Специфическое в отношении fapa-(протеин альфа активации фибробласта) антитело с повышенной продуктивностью
ES8602121A1 (es) Procedimiento para producir un vehiculo de expresion para la formacion de uroquinasa humana
DE60136099D1 (de) Zusammensetzungen zur behandlung und diagnose von eierstockkrebs
TR200102497T2 (tr) Yeni streptococcus antijenleri
DE68929256D1 (de) Humaner Rezeptor Fc(gamma)RIII
FI830100L (fi) Nya 6-substituerade s-triazolo /3,4-a/ ftalazinderivat
EP0552296A4 (en) Mouse monoclonal antibodies
AU8172094A (en) Synthetic HTLV-III peptides, compositions and uses thereof
BR9810907A (pt) Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico
ATE70280T1 (de) Charakteristische polypeptide und antikoerper vom papillomavirus, diagnostische verfahren und dieselben verwendende impfungen.
HU9201552D0 (en) Medical preparation for the neutralization of procoagulant activity cused by tumorous cells
NL190399B (nl) Ijzer-bevattend eiwitmateriaal, bereiding daarvan, en farmaceutisch preparaat voor de behandeling van sideropene anaemie.
ES2111757T3 (es) Regiones antigenicas de complejos de particulas liberadas por tumores (tlp) y anticuerpos contra los mismos.
AU9363398A (en) Hepatitis c receptor protein cd81
DE69030494T2 (de) Karzinomverwandtes haptoglobin (hpr)
EP0109434A4 (en) IN VITRO DIAGNOSTICS METHODS USING MONOCLONAL ANTIBODIES AGAINST PROTEINS OF CONNECTIVE TISSUES.
ES2061566T3 (es) Anticuerpos monoclonales contra la proteina e7 del papilomavirus humano tipo 16, procedimiento para su preparacion, asi como su empleo.
IT8021411A0 (it) Polipeptide sintetico attivo come antigene, e procedimento per la sua preparazione.
PT86944A (pt) Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben
DE69930942D1 (de) Hla-a2 beschränktes tumorantigen-peptid, das von sart-1 abstammt
AU653332B2 (en) Synthetic peptides which contain sequences from factor VIIa, and the use thereof
ATE209041T1 (de) Durch hla-b44 moleküle präsentierte tumor- abstossungsantigene und ihre verwendung
FR1552939A (es)
FI883765A (fi) Antikroppar mot biologiskt aktiva polypeptider och deras anvaendning vid diagnostiska foerfaranden.
ATE17190T1 (de) Mittel zur tumorlokalisierung und therapie mit markierten antikoerpern und antikoerperfragmenten.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 649433

Country of ref document: ES